Twin Tree Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.11M Sell
27,000
-10,300
-28% -$702K 0.04% 552
2026
Q1
$2.41M Buy
+37,300
New +$2.63M 0.05% 415
2025
Q3
Sell
-100
Closed -$5.2K 1612
2025
Q2
$5.2K Sell
100
-11,500
-99% -$654K ﹤0.01% 1543
2025
Q1
$740K Sell
11,600
-89,000
-88% -$5.17M ﹤0.01% 1305
2024
Q4
$4.81M Buy
+100,600
New +$5.16M 0.01% 936
2024
Q3
Sell
-8,600
Closed -$450K 1619
2024
Q2
$450K Buy
8,600
+2,000
+30% +$87.7K ﹤0.01% 1124
2024
Q1
$268K Hold
6,600
﹤0.01% 1137
2023
Q4
$244K Buy
+6,600
New +$249K ﹤0.01% 1243

Other funds holding HALO

Twin Tree Management's HALO Position: Q2 2026 in Review

Twin Tree Management sold out of Halozyme (HALO) in Q2 2026, closing a stake of 10,248 shares — an estimated $699K sold.

Twin Tree Management first reported a position in HALO in Q4 2020 and held it in 12 quarters. The position peaked at $1.96M in Q4 2022. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Twin Tree Management reported no remaining Halozyme position as of Q2 2026 after selling out during the quarter.
  • Twin Tree Management sold 10,248 Halozyme shares in Q2 2026, an estimated $699K.
  • Twin Tree Management first reported a position in Halozyme in Q4 2020 and held it in 12 quarters.
  • Twin Tree Management's Halozyme position peaked at $1.96M in Q4 2022.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Twin Tree Management's 13F filing for Q2 2026, filed 12 Aug 2026.